(Q30544595)

18 August 2017

Pretreatment EEG in childhood absence epilepsy: associations with attention and treatment outcome (English)

1 reference

childhood absence epilepsy

18 August 2017

1 reference

3

Avital Cnaan

1 reference

18 August 2017

Dennis Dlugos

1

1 reference

18 August 2017

Shlomo Shinnar

2

1 reference

18 August 2017

Fengming Hu

4

1 reference

18 August 2017

Solomon Moshé

5

1 reference

18 August 2017

Eli Mizrahi

6

1 reference

18 August 2017

David Masur

7

1 reference

18 August 2017

Yoshi Sogawa

8

1 reference

18 August 2017

J B Le Pichon

9

1 reference

18 August 2017

Calley Levine

10

1 reference

18 August 2017

Deborah Hirtz

11

1 reference

18 August 2017

Peggy Clark

12

1 reference

18 August 2017

Peter C Adamson

13

1 reference

18 August 2017

Tracy Glauser

14

1 reference

18 August 2017

Childhood Absence Epilepsy Study Team

15

1 reference

18 August 2017

language of work or name

English

0 references

publication date

29 May 2013

1 reference

18 August 2017

1 reference

18 August 2017

81

1 reference

18 August 2017

2

1 reference

18 August 2017

150-156

1 reference

Ethosuximide, valproic acid, and lamotrigine in childhood absence epilepsy: initial monotherapy outcomes at 12 months

18 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3770172

Ethosuximide, valproic acid, and lamotrigine in childhood absence epilepsy

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3770172

Lamotrigine monotherapy for newly diagnosed typical absence seizures in children

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3770172

The outcome of absence epilepsy: a meta-analysis.

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3770172

Proposal for revised classification of epilepsies and epileptic syndromes. Commission on Classification and Terminology of the International League Against Epilepsy

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3770172

Childhood absence epilepsy: Elctroclinical features and diagnostic criteria

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3770172

Lamotrigine versus valproic acid as first-line monotherapy in newly diagnosed typical absence seizures: an open-label, randomized, parallel-group study.

26 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3770172

Neuropsychological assessment in children with absence epilepsy.

26 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3770172

Lamictal (lamotrigine) monotherapy for typical absence seizures in children

26 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3770172

How well can epilepsy syndromes be identified at diagnosis? A reassessment 2 years after initial diagnosis

26 November 2018

1 reference

12 December 2020

Newly diagnosed unprovoked epileptic seizures: presentation at diagnosis in CAROLE study. Coordination Active du Réseau Observatoire Longitudinal de l' Epilepsie

1 reference

12 December 2020

Comparative study of ethosuximide and sodium valproate in the treatment of typical absence seizures (petit mal)

1 reference

12 December 2020

1 reference

12 December 2020

Long-term psychosocial outcome in typical absence epilepsy. Sometimes a wolf in sheeps' clothing

1 reference

12 December 2020

Electroclinical features of absence seizures in childhood absence epilepsy

1 reference

12 December 2020

10.1212/WNL.0B013E31829A3373

Identifiers

DOI

1 reference

18 August 2017

1 reference

18 August 2017

PubMed publication ID

23719147

1 reference